Lundin Gold: Canaccord Says Fruta Del Norte Mine Ranks Among Best In World

Lundin Gold Inc. (TSX: LUG) on Tuesday provided investors with a three-year outlook. The company expects gold production to be between 425,000 and 475,000 ounces in 2023, rising up to between 465,000 and 515,000 ounces by 2025. During the same time, all-in-sustaining costs are expected to drop from $870 to $940 an ounce to $800 to $870 an ounce. Of that, cash costs are expected to be $700 to $760 in 2023, decreasing to between $640 and $700 an ounce.

Lundin Gold says that the 2023 gold production estimate is based on an average throughput rate of 4,400 tpd with an average head grade of 9.67 gold per tonne. Though they expect fluctuations during the year, “as different sections of the ore body are mined.” Additionally, they say that cash costs are expected to jump around for 2023.

Lastly, Lundin Gold said that they will be continuing their near mine and regional exploration programs and are planning 28,000 meters of drilling. While the near mine program is expected to drill 15,500 metres and cost $9.4 million.

Lundin Gold has ten analysts covering the stock with an average 12-month price target of C$13.75, or an upside of about 10%. Out of the ten analysts, one has a strong buy rating, six have buy ratings, and the last three analysts have hold ratings on the stock. The street-high price target comes in at C$15.50 from three analysts and represents an upside of about 23%.

In Canaccord Genuity Capital Markets’ note on the results, they reiterate both their buy rating and C$15.00 long-term price target, saying that this update, “delivered in a big way, featuring significantly increased expectations.”

Canaccord also believes that the guidance of the mine hitting 500k production, “should attract plenty of attention.” In contrast, the mine has relatively stable all-in-sustaining costs over the next three years. They say that an all-in-sustaining cost of under $900 an ounce is “extremely attractive” and that this low cost “underscores its status as a true cornerstone asset” for the company.

Canaccord adds that FDN would “rank among the best mines in the world” if it were to just hit the midpoint of Lundin Gold’s 2025 guidance. It would also put the mine in the top 6% of production and the bottom 20% of all-in-sustaining costs for primary gold mines. They expect the first quarter of 2023, when the company is expected to give an R&R update for the mine, to be a key event.

Below you can see Canaccord’s updated estimates.


Information for this briefing was found via Edgar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

SSR Mining Walks Away From a World Class Gold-Copper Project

Why More Canadians Are Starting to Think About Leaving | Jesse Day

Instead of Waiting, This Gold Developer Went Bigger | Kenneth McLeod – Sonoro Gold

Recommended

Why This Gold Company Keeps Spinning Out Assets | John-Mark Staude – Riverside Resources

Silver at $75 and Why U.S. Silver Ounces Are Getting Hard to Find | Galen McNamara – Silver47

Related News

Lundin Mining Sees BMO Drop Price Target Following Unfortunate Weekend

Lundin Mining (TSX: LUN) had a weekend of unfortunate press releases. The first of which...

Tuesday, September 29, 2020, 03:37:52 PM

Canaccord Genuity Initiates Coverage On Artemis Gold With C$13 Price Target

Canaccord Genuity initiated coverage on Artemis Gold (TSXV: ARTG) this morning with a Speculative Buy...

Thursday, September 10, 2020, 03:00:12 PM

Tesla: Consensus Earnings Expectations For Q2

Tesla (NASDAQ: TSLA) will be reporting their second quarter financial results on July 26th after...

Sunday, July 25, 2021, 11:33:00 AM

Lundin Mining Sees BMO Maintain Price Target Following Q3 Earnings

Yesterday Lundin Mining (TSX: LUN) reported their third quarter earnings. Third-quarter cash flows were +$272.2...

Thursday, October 29, 2020, 03:29:00 PM

Canaccord Slashes Antibe Therapeutics Price Target A Month After Drug Trial Paused

On August 3, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Wednesday, September 29, 2021, 11:44:00 AM